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The introduction of drug-eluting stents and advances in catheter techniques have led to increasing acceptance of
percutaneous coronary intervention (PCI) as a viable alternative to coronary artery bypass graft (CABG) for unpro-
tected left main disease. Current guidelines state that it is reasonable to consider unprotected left main PCI in
patients with low to intermediate anatomic complexity who are at increased surgical risk. Data from randomized
trials involving patients who are candidates for either treatment strategy provide novel insight into the relative
safety and efficacy of PCI for this lesion subset. Herein, we review the current data comparing PCI with CABG for
left main disease, summarize recent guideline recommendations, and provide an update on technical consider-
ations that may optimize clinical outcomes in left main PCI. (J Am Coll Cardiol 2012;60:1605–13) © 2012 by
the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.01.0850More than 30 years have passed since the first—and
failed—attempt at left main percutaneous coronary inter-
vention (PCI) by Andreas Gruentzig. Given the low prev-
alence of this lesion subset, robust data from dedicated
randomized controlled trials (RCTs) comparing PCI with
coronary artery bypass graft (CABG) are lacking, and
CABG remains the traditional standard for the treatment of
left main obstruction according to society guidelines (1).
The introduction of drug-eluting stents (DES), combined
with a culture within interventional cardiology that pro-
motes shared experience through prompt dissemination of
new techniques and outcomes, has led to a rapid evolution
in the percutaneous approach to left main disease and broad
clinical adoption of PCI that outpaces current guidelines.
Herein, we summarize these guidelines, review the current
state of observational and RCT data that pertain to left
main intervention, and provide an update on technical
considerations that may optimize clinical outcomes in left
main PCI.
RCTs of Left Main PCI Disease
Compared With CABG
To date, 4 RCTs have compared the efficacy of PCI with
CABG for the treatment of left main disease, 1 using
surrogate endpoints and 3 having a noninferiority design
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2012, accepted January 20, 2012.(Table 1). The LE MANS (Study of Unprotected Left
Main Stenting Versus Bypass Surgery) enrolled 105 patients
with 50% left main narrowing, with or without multives-
sel coronary artery disease, who were equally suitable for
PCI or CABG (2). The primary endpoint was the change in
left ventricular ejection fraction according to echocardiog-
raphy at 12 months; clinical outcomes were key secondary
endpoints. At 1-year follow-up, the mean ejection fraction
increased with PCI compared with CABG (3.3  6.7% vs.
.5  0.8%, p  0.047), resulting in a greater ejection
fraction in the PCI group (58.0  6.8% vs. 54.1  8.9%,
p  0.01). The risk of major adverse cardiac and cardiovas-
cular events (MACCE) at 30 days was lower with PCI (2%
vs. 13%; relative risk: 0.88 [95% confidence interval (CI):
0.79 to 0.99]; p  0.03), whereas the risk of MACCE at 1
year was similar (31% vs. 25%; relative risk: 1.09 [95% CI:
0.85 to 1.38]), primarily due to the need for repeat revas-
cularization in the PCI group. Left main restenosis occurred
in 5 patients (9.6%), 4 of whom had received bare-metal
stents (BMS). At a longer-term follow-up of 28.0  9.9
months, there was a trend toward better survival after PCI
(p  0.08).
The SYNTAX (Synergy Between Percutaneous Coro-
nary Intervention with TAXUS and Cardiac Surgery) trial
provides the largest randomized dataset from which to
assess the early and longer-term safety and efficacy of PCI
for left main disease (3,4). A total of 1,800 patients with
3-vessel and/or left main disease (angiographic stenosis
50%) were randomly assigned to PCI with paclitaxel-
eluting stents or to CABG; randomization was stratified
according to the presence or absence of left main disease.
The primary endpoint was MACCE at 1 year, and PCI
would be deemed noninferior to CABG if the upper bound
of the 95% CI for the absolute risk difference between the 2
strategies was 6.6%. The prespecified statistical analysis
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Left Main PCI October 23, 2012:1605–13plan was to first compare the
overall population, with the left
main subgroup compared subse-
quently only if noninferiority was
concluded for the overall com-
parison. PCI was not noninferior
to CABG for the prevention of
MACCE in the overall trial
(17.8% vs. 12.4%) (3), and there-
fore the findings within the left
main cohort must be interpreted
as observational and hypothesis-
generating only. The trial used a
novel method to calculate angio-
graphic complexity, called the
SYNTAX score, which incorpo-
rates the number of lesions, lesion
location, lesion length, the pres-
ence of chronic total occlusions, bi-
furcations or trifurcations, aorto-
osital stenoses, vessel tortuosity,
calcification, thrombus, and diffuse
disease. A higher SYNTAX score
reflects greater anatomic complex-
ity. Among the 750 patients in
the unprotected left main cohort,
the mean EuroSCORE (a mea-
sure of surgical risk) was 3.9, the
mean SYNTAX score was 30,
and slightly more than one-third
of the patients had 3-vessel dis-
ease in addition to left main ob-
struction. The 1-year MACCE
rates were similar for PCI and CABG (15.8% vs. 13.7%,
p  0.48), with significantly lower rates of repeat revascu-
larization in the patients randomly assigned to CABG
(11.8% vs. 6.5%, p 0.02) at the cost of more strokes (0.3%
Abbreviations
and Acronyms
ACCF  American College
of Cardiology Foundation
AHA  American Heart
Association
BMS  bare metal stent(s)
CABG  coronary artery
bypass graft
CI  confidence interval
DES  drug-eluting stent(s)
FFR  fractional flow
reserve
HR  hazard ratio
IVUS  intravascular
ultrasound
MACCE  major adverse
cardiac and cardiovascular
events
MACE  major adverse
cardiovascular events
MI  myocardial infarction
MLA  minimal luminal
area
OR  odds ratio
PCI  percutaneous
coronary intervention
RCT  randomized
controlled trial
SCAI  Society of
Cardiovascular Angiography
and Interventions
Completed and Planned RCTs of PCI Compared With CABG for theTable 1 Completed and Planned RCTs of PCI Compared With C
Trial Name n Follow-up Primary Endpoint
Even
PCI
LE MANS 105 1 yr Change in LVEF 3.3 6.7%
Boudriot et al. (6) 201 1 yr Death, MI, TVR 19%
PRECOMBAT 600 1 yr Death, MI, TVR, CVA 8.7%
SYNTAX 705 3 yrs Death, MI, TVR, CVA 26.8%
EXCEL 2,634 3 yrs Death, MI, CVA NA
MILESTONE 1,000 1 yr Death NA
*Noninferiority comparison.
CABG  coronary artery bypass graft; CAD  coronary artery disease; CVA  cerebrovascular e
ersus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization; LE MANS
Imyocardial infarction; MILESTONE Revascularization Strategy (PCI With DES Implantation v
eft Main Coronary Disease; NA  not applicable; PCI  percutaneous coronary intervention
irolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease; RCT  randomized clinical tri
axus and Cardiac Surgery; TVR  target vessel revascularization.vs. 2.7%, p  0.009). In patients with low and intermediate
SYNTAX scores (0 to 22 and 23 to 32), 1-year MACCE
rates were numerically lower with PCI (7% vs. 13% [p 
.19]; 12.6% vs. 15.5% [p  0.54]), whereas in those with
YNTAX scores 32, MACCE rates after CABG were
ignificantly better (25.3% vs. 12.9%, p  0.008). At the
-year follow-up, there continued to be no significant
ifference within the overall left main cohort in the rate of
ACCE between treatment strategies (26.8% vs. 22.3%,
 0.20); repeat revascularization was still more frequent
with PCI (20.0% vs. 11.7%, p  0.004), whereas the risk of
troke after PCI remained lower (1.2% vs. 4.0%, p  0.02)
Fig. 1) (5). Consistent with the 1-year results, patients with
he greatest anatomic complexity (SYNTAX score 32)
ad inferior outcomes when treated with PCI at 3 years
MACCE rates: 37.3% vs. 21.2%; p  0.003). With regard
o safety, patients randomized to PCI had a numerically
ower but not significantly different rate of the composite
ndpoint of death, myocardial infarction (MI), or stroke
13.0% vs. 14.3%, p 0.60) and of all-cause death (7.3% vs.
.4%, p  0.64). Therefore, within SYNTAX, with the
xception of the highest-risk anatomy (SYNTAX score
32), unprotected left main PCI seemed to be as safe as
ABG at 3 years, and PCI outcomes were most favorable in
he patients with low to intermediate anatomic complexity.
lthough there are many limitations to the SYNTAX trial,
t currently remains the largest RCT comparing PCI with
ABG in a prespecified left main subgroup.
Although the SYNTAX trial stratified randomization
ccording to the presence of left main disease and prespeci-
ed the left main subgroup as a secondary analysis, Boudriot
t al. (6) performed a small, multicenter, randomized trial
edicated to patients with significant (50%) left main
isease. The goal of the trial was to assess whether PCI with
irolimus-eluting stents would be noninferior to CABG
ith respect to the rate of the combined endpoint of death,
I, and repeat revascularization. Patients who had chronic
tment of Unprotected Left Main CADfor the Treatment of Unprotected Left Main CAD
p Value
Major
Secondary
Endpoint
Event Rate
p ValueABG PCI CABG
 0.8% 0.047 Death, MI, TVR,
CVA, ST
30.7% 24.5% NS
3.9% 0.19* Death, MI 5.0% 7.9% 0.01*
6.7% 0.01* Death, MI, CVA 3.3% 4.0% 0.83
2.3% 0.20 Death, MI, CVA 13.0% 14.3% 0.60
NA Noninferiority and
superiority
Death, MI, TVR NA NA NA
NA Noninferiority Death, MI, CVA,
TVR
NA NA NA
CEL  Evaluation of XIENCE PRIME Everolimus Eluting Stent System (EECSS) or XIENCE V EECSS
of Unprotected Left Main Stenting Versus Bypass Surgery; LVEF left ventricular ejection fraction;
) in Patients With Non ST Elevation Acute Coronary SyndromeWith Multivessel and/or Unprotected
OMBAT  Premier of Randomized Comparison of Bypass Surgery versus Angioplasty UsingTreaABG
t Rate
C
0.5
1
2
vent; EX
Study
s CABG
; PRECal; ST  stent thrombosis; SYNTAX  Synergy between Percutaneous Coronary Intervention with
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October 23, 2012:1605–13 Left Main PCItotal occlusions, lesions 30 mm, and “extreme” left-
ominant coronary systems were excluded. A total of 201
atients were enrolled, providing 80% power assuming a
5% event rate in the surgical group and an allowable
elative risk difference of 10% between groups. Enrolled
atients had lower anatomic and surgical risk compared
ith those in the SYNTAX trial: the mean SYNTAX score
as 23.5, the mean logistic EuroSCORE was 2.5, and 14%
ad concomitant 3-vessel disease. A median of 2 sirolimus-
luting stents per patient were implanted in the PCI group,
nd 65% of the CABG group received total arterial revas-
ularization. Compared with PCI, significant periproce-
ural adverse events occurred more frequently after CABG
4% vs. 30%, p  0.001). At 12-month follow-up, the
ombined endpoint of death, MI, and repeat revasculariza-
ion occurred in 19% of patients after PCI and in 13.9% of
atients after CABG, and therefore PCI did not satisfy the
tatistical criteria for noninferiority (p  0.19). The differ-
ence between groups was driven by increased repeat revas-
cularization in the patients undergoing PCI (14.0% vs.
5.9%). PCI was noninferior to CABG with respect to the
secondary endpoints of death (2% vs. 5%; 95% CI for
differences:9.4 to 2.7; p 0.001) and death or MI (5% vs.
7.9%; 95% CI for differences: 10.6 to 4.4; p  0.001),
although these observations must be considered hypothesis-
generating given that the trial did not achieve its primary
endpoint. The rate of death and MI remained similar
between groups at an average of 3 years of follow-up.
Therefore, the results of this small trial are consistent
with those of SYNTAX and suggest that compared with
a surgical cohort treated with optimal arterial revascular-
ization, left main PCI with sirolimus-eluting stents in
patients at relatively low surgical risk and without highly
complex anatomy provides a similar longer-term rate of
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Figure 1 3-Year Clinical Outcomes in Patients With Left Main D
p values from log-rank test. CABG  coronary artery bypass graft; MACCE  majo
PCI  percutaneous coronary intervention; Revasc  repeat revascularization; SYN
Surgery. Adapted from Kappetein et al. (5).death and MI at the cost of more repeat procedures. gUniquely, this trial prospectively assessed the morbidity
of the 2 treatment strategies and demonstrated that any
differences in “hard endpoints” must be interpreted in the
context of a greater risk of periprocedural events with
CABG, including atrial fibrillation, major infection, and
stroke.
The PRECOMBAT (Premier of Randomized Com-
parison of Bypass Surgery Versus Angioplasty Using
Sirolimus-Eluting Stent in Patients with Left Main
Coronary Artery Disease) trial is the largest dedicated
unprotected left main RCT to compare DES with CABG
to date (7). The primary endpoint was the composite of
death, MI, ischemia-driven target vessel revascularization,
and stroke at 1-year follow-up. A total of 600 patients
suitable for either treatment approach were enrolled, which
provided 80% power to show noninferiority assuming a 13%
event rate in the CABG group and an absolute risk
difference7%. The enrolled population was at low surgical
risk, with a mean EuroSCORE of 2.7, and the coronary
anatomy was less complex than SYNTAX (mean SYNTAX
score: 25). According to the criteria used in the trial, the
1-year rate of the primary endpoint after PCI was nonin-
ferior to CABG (8.7% vs. 6.7%; absolute risk difference:
2.0% [95% CI: 1.6 to 5.6]; p  0.01). At 2 years, the rate
f death, MI, and stroke was numerically lower with PCI
nd did not differ between the groups (4.4% vs. 4.7%;
azard ratio [HR]: 0.92 [95% CI: 0.43 to1.96]; p  0.83),
lthough repeat revascularization was significantly higher
fter PCI (9.0% vs. 4.2%; HR: 2.18 [95% CI: 1.10 to 4.32];
 0.02). This increased rate of repeat revascularization
as restricted to the patients who had concomitant 3-vessel
isease. The findings of PRECOMBAT have substantial
imitations. The study was underpowered given the lower-
han-expected rates of the primary endpoint in the CABG
Death/MI/Stroke Revasc MACCE
p=0.60
p=0.004
p=0.20
se in the SYNTAX Trial, According to Treatment Group
se cerebrovascular and cardiovascular events; MI  myocardial infarction;
Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac14
isea
r adver
TAX roup, and the margin for noninferiority was set so wide
1608 Teirstein and Price JACC Vol. 60, No. 17, 2012
Left Main PCI October 23, 2012:1605–13that PCI was deemed noninferior despite possibly resulting
in nearly twice the MACCE as CABG. However, the
apparent safety of PCI compared with CABG at 2 years is
consistent with that observed in SYNTAX.
Meta-analyses and registries. Several meta-analyses of
observational and randomized studies comparing the safety
and efficacy of PCI with CABG have been conducted.
Among 2,905 patients from 8 studies comparing DES with
CABG, there were no differences in the risk of death, MI,
or stroke at 1 year (odds ratio [OR]: 1.25 [95% CI: 0.86 to
1.82]) or the risk of death alone (OR: 1.12 [95% CI: 0.80 to
1.56]), whereas repeat revascularization was significantly
reduced with CABG (OR: 0.44 [95% CI: 0.32 to 0.59]) (8).
Similarly, in 10 studies involving 3,773 patients with un-
protected left main stenosis treated with PCI using DES or
BMS or with CABG, the risk of death, MI, or stroke was
similar at 3 years (OR: 1.16 [95% CI: 0.68 to 1.98]) as was
mortality alone (OR: 1.11 [95% CI: 0.66 to 1.86]), whereas
the risk of repeat revascularization was greater with PCI
(OR: 3.30 [95% CI: 0.96 to 11.33]) (9). At 5-year follow-up
in the MAIN-COMPARE registry, there was no signifi-
cant difference between PCI with DES or CABG in the
adjusted risk of death (HR: 0.83 [95% CI: 0.34 to 2.07]) or
in the risk of the composite of death, Q-wave MI, or stroke
(HR: 0.91 [95% CI: 0.45 to 1.83]); the risk of the primary
efficacy endpoint, target vessel revascularization, was signif-
icantly higher with DES (HR: 6.22 [95% CI: 2.26 to
17.14]) (10). Recent registry data also support a significant,
negative interaction between anatomic complexity and out-
come after PCI compared with CABG (11). In 1,146
patients with unprotected left main disease who received
either DES or CABG, the adjusted risk of morality at 5
years favored PCI in patients with low SYNTAX scores
(23) (HR: 0.52 [95% CI: 0.21 to 1.28]; p  0.15) but
favored CABG in patients with high SYNTAX scores
(32) (HR: 1.46 [95% CI: 0.92 to 2.30]; p  0.11, p
interaction  0.047) (12).
Several tentative conclusions regarding left main PCI can
be drawn from the current evidence base of trial data, which
involve a total of 1,600 randomized patients. First, PCI
may provide at least equivalent results to CABG in the
setting of less complex anatomy, as the rates of death and
the combined endpoint of death, MI, and stroke are similar
between PCI with “first-generation” DES and CABG up to
3 years of follow-up, with a numerical advantage favoring
PCI across the trials. Several meta-analyses of observational
and randomized comparisons of PCI and CABG similarly
demonstrate no differences in mortality up to the 3-year
follow-up (8,9,13). These findings must be interpreted with
caution because these studies were underpowered, and the
left main disease data from SYNTAX are based on a
subgroup analysis of a negative trial (3,4). The durability of
PCI, especially in patients who have intermediate SYNTAX
scores, must be confirmed with continued follow-up. Sec-
ond, PCI seems to be inferior to CABG with respect to the
composite of death, MI, and stroke, as well as death alone,in patients with greater anatomic complexity (SYNTAX scores
32) or when considering the endpoint of repeat revascu-
larization. “Next-generation” DES with better safety and
clinical outcomes and more objective approaches to revas-
cularization may further optimize PCI outcomes. This
hypothesis is being tested in the EXCEL (Evaluation of
XIENCE PRIME Everolimus Eluting Stent System
[EECSS] or XIENCE V EECSS Versus Coronary Artery
Bypass Surgery for Effectiveness of Left Main Revascular-
ization) trial (NCT01205776), which will examine the
safety and efficacy of PCI with everolimus-eluting stents
compared with CABG in approximately 2,600 patients with
unprotected left main disease who are eligible for either
treatment strategy and have SYNTAX scores 32. The
primary endpoint is the composite of death, MI, or stroke at
3 years, and the trial is powered for sequential noninferiority
and superiority testing. The rate of repeat revascularization,
which in previous clinical trials has favored CABG, will be
considered a secondary endpoint, and therefore the overall
clinical efficacy of PCI within the trial will need to be
interpreted within this context.
Acute coronary syndrome and left main PCI. Left main
disease is rare in patients presenting with acute coronary
syndrome. In the GRACE (Global Registry of Acute
Coronary Events) registry, the incidence of significant
unprotected left main obstruction was approximately 4%
(14). Data regarding clinical outcomes in this patient cohort
are limited to small observational studies that suffer from
substantial confounding. Patients with acute MI and a left
main culprit lesion are more frequently in cardiogenic shock
and are more likely to have suffered cardiac arrest before
intervention compared with patients with culprit lesions in
other parts of the coronary tree (15,16). Among PCI
registries, in-hospital mortality is high (21% to 58%) and is
related to the prevalence of cardiogenic shock within the
cohort studied, but patients surviving hospitalization seem
to have an excellent long-term prognosis (16). In the
GRACE registry, left main revascularization by PCI or
CABG was associated with improved survival after dis-
charge compared with no revascularization. PCI patients
had greater unadjusted rates of in-hospital mortality (11%
vs. 5.4%) and 6-month out-of-hospital mortality (5.4% vs.
1.6%) with fewer strokes (0.4% vs. 2.1%), although CABG-
treated patients were at substantially lower clinical risk (14).
Because left main PCI has the advantage of providing more
rapid reperfusion compared with CABG with acceptable
short- and longer-term outcomes, and is associated with a
lower risk of stroke, some have opined that PCI should be
considered for the treatment of patients presenting with
acute MI and a left main culprit lesion, particularly those
who experience cardiogenic shock, persistent ventricular
arrhythmias, slow flow, and significant comorbidities (17).
Current guidelines recommend PCI in patients presenting
with acute coronary syndrome who are not suitable candi-
dates for CABG (Class IIa, Level of Evidence: B) or in
patients with ST-segment elevation MI due to a left main
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October 23, 2012:1605–13 Left Main PCIculprit lesion with reduced Thrombolysis In Myocardial
Infarction flow and in whom PCI can be performed more
quickly and safely than CABG (Class IIa, Level of Evi-
dence: C) (Table 2).
Society guidelines. The 2011 American College of Cardi-
ology Foundation (ACCF)/American Heart Association
(AHA)/Society of Cardiovascular Angiography and Inter-
ventions (SCAI) Guidelines for PCI provide detailed rec-
ommendations regarding left main revascularization that
have been revised substantially from prior versions (Table 2)
(1). First, the guidelines state that a heart team approach
should be used in the management of these patients (Class
I, Level of Evidence: C), which is consistent with the
protocols of several of the recent left main PCI studies,
including SYNTAX. Second, anatomic risk stratification
according to the SYNTAX score and surgical risk stratifi-
cation according to the Society of Thoracic Surgeons’ score
are recommended (Class IIa, Level of Evidence: B). The
guidelines incorporate the relation between coronary anat-
omy and adverse outcomes after left main PCI that was
observed in randomized studies: consideration for PCI
rather than CABG is based on the degree of anatomic
complexity (for SYNTAX score 22 or ostial/shaft disease,
Class IIa; for SYNTAX score 33 or distal bifurcation
disease, Class IIb). The guidelines restrict the recommen-
dation to consider PCI only in those patients at increased
surgical risk, although the RCTs of left main PCI included
patients who were candidates for either treatment approach.
The European Society of Cardiology and the European
Association for Cardio-Thoracic Surgery Guidelines on
myocardial revascularization address the indications for
CABG compared with left main PCI in stable patients with
Recommendations Pertaining to Unprotected Left Main InterventioAmerican Heart Associatio /S ciety f Cardiovascul r A giographTable 2 Recommendations Per aining to Unprotected Left MaiAmerican Heart Association/Society of Cardiovascular
Classification Level of Evidence
I C A heart team approach to revascular
or complex CAD
IIa B Calculation of the STS and SYNTAX s
IIa B IVUS is reasonable for the assessmen
IIb B IVUS may be considered for guidance
IIa B PCI to improve survival is reasonable
unprotected left main CAD with: 1
high likelihood of a good long-term
characteristics that predict a signi
mortality 5%)
IIa B PCI to improve survival is reasonable
culprit lesion and the patient is no
IIa C PCI to improve survival is reasonable
culprit lesion, distal coronary flow
IIb B PCI to improve survival may be reaso
unprotected left main CAD with: 1
complications and an intermediate
33, bifurcation left main CAD); a
III (harm) B PCI to improve survival should not be
unfavorable anatomy for PCI and w
CABG  coronary artery bypass graft; CAD  coronary artery disease; IVUS  intravascular ultraso
etween Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery; TIMI  Thrombolysis I
nfarction.lesions suitable for both procedures and low predicted
surgical mortality (18). These guidelines provide a Class IIa
(Level of Evidence: B) recommendation for PCI of left
main ostial or shaft disease when it exists in isolation or in
combination with 1-vessel disease; a Class IIb (Level of
Evidence: B) recommendation for left main distal bifurca-
tion disease when it exists in isolation or in combination
with 1-vessel disease; a class IIb recommendation for any
left main disease with concomitant 2- or 3-vessel disease
and a SYNTAX score 32; and a Class III recommenda-
tion for left main disease with concomitant 2- or 3-vessel
disease and a SYNTAX score 33. CABG is the favored
approach for all of these scenarios (Class I, Level of
Evidence: A).
Procedural Considerations
Assessing the severity of left main obstruction. Due to
he short length of the left main and the diffuse nature of the
isease, angiographic determination of the severity of left
ain disease is notoriously less reliable compared with other
ocations in the coronary tree (Fig. 2) (19). Further invasive
valuation should be strongly considered in the setting of a
esion of indeterminate severity or discordance between
ngiographic views. When performing intravascular ultra-
ound (IVUS), it is important to image the left main
eginning in the daughter vessel with the least angulated
ccess, usually the left anterior descending artery, especially
hen assessing disease of the distal left main. A minimal
uminal area (MLA) 6 mm2 has been proposed as the
riteria for a significant left main obstruction according to
urray’s law, based on an MLA threshold of 4 mm2 for
he American College of Cardiology Foundation/Interv ntio 2011 Guidelines f r PCIrvention in the American College of Car iology Foundation/
iography and Intervention 2011 Guidelines for PCI
Recommendation
is recommended in patients who have unprotected left main disease
s reasonable in patients who have unprotected left main and complex CAD
giographically indeterminate left main CAD
onary stent implantation, particularly in cases of left main coronary artery stenting
alternative to CABG in selected patients whose disease is stable with significant
mic conditions associated with a low risk of PCI procedural complications and a
me (e.g., a low SYNTAX score [22], ostial or trunk left main CAD); and 2) clinical
increased risk of adverse surgical outcomes (e.g., STS-predicted risk of operative
ients who have UA/NSTEMI when an unprotected left main coronary artery is the
didate for CABG
ients who have acute STEMI when an unprotected left main coronary artery is the
flow grade 3, and PCI can be performed more rapidly and safely than CABG
as an alternative to CABG in selected stable patients who have significant
mic conditions associated with a low to intermediate risk of PCI procedural
h likelihood of good long-term outcome (e.g., low-intermediate SYNTAX score of
clinical characteristics that predict an increased risk of adverse surgical outcomes
rmed in stable patients with significant unprotected left main CAD who have
e good candidates for CABG
I  percutaneous coronary intervention; STS  Society of Thoracic Surgeons; SYNTAX  Synergyn in ty a dI te
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Left Main PCI October 23, 2012:1605–13the left anterior descending and left circumflex arteries. This
cutoff has been shown to have a high sensitivity and
specificity to predict a fractional flow reserve (FFR) 0.75
(20). Recently, in a single-center study of 55 patients with
isolated, de novo left main disease of indeterminate severity,
an MLA 4.8 mm2 provided 89% sensitivity and 83%
pecificity to predict an FFR 0.80 (21). A prospective,
ulticenter trial involving 354 patients who had interme-
Figure 2 Evaluation of an
Angiographically Indeterminate Left Main Lesion
(A) Left coronary angiography in cranial projection, showing hazy nonobstruc-
tive lesion of the distal bifurcation (arrow). (B) Optical coherence tomography
demonstrates significant luminal narrowing due to atherosclerotic plaque just
proximal to the left circumflex and left anterior descending ostia. The minimal
luminal area was 5.4 mm2, less than the threshold of 6 mm2 that has been
suggested to define clinically important luminal narrowing (20,22). Current
American College of Cardiology Foundation/American Heart Association/Society
of Cardiovascular Angiography and Interventions guidelines for percutaneous
coronary intervention state that intravascular ultrasound is reasonable for the
assessment of angiographically indeterminate left main coronary artery disease
(Class IIa, Level of Evidence: B).iate unprotected left main lesions demonstrated that de- terring revascularization for lesions with an MLA 6 mm2
was safe, resulting in a 2-year cardiac death-free survival rate
of 97.7% (22). The 2011 ACCF/AHA/SCAI guidelines for
PCI state that IVUS is reasonable for the assessment of
angiographically indeterminate left main coronary artery
disease (class IIa, Level of Evidence: B) (1).
An FFR 0.80 has also been validated for the diagnosis
of left main obstruction, and an FFR-guided strategy
between medical therapy or CABG provides favorable
long-term outcomes (23). In the setting of concomitant
lesions of the left anterior descending and/or left circumflex
arteries, FFR may be challenging to interpret. Unlike FFR,
IVUS provides plaque morphologic and anatomic data that
can help guide and optimize PCI (24,25). Optical coherence
tomography imaging can also provide detailed plaque mor-
phology and anatomy (Fig. 1), although ostial left main
lesions cannot be assessed with this technology because
intubation of the left main with the coronary guiding
catheter and contrast injection is required to provide a
blood-free lumen.
Stenting approach. BMS OR DES. A meta-analysis of ob-
servational studies and RCTs involving 10,342 patients
demonstrated lower crude event rates for DES than BMS
for mortality, repeat revascularization, and major adverse
cardiovascular events (MACE) at 6 to 12 months, 2 years,
and 3 years (26). Adjusted analyses of 5,081 patients
demonstrated a significantly lower risk of mortality with
DES at the 2-year (OR: 0.42 [95% CI: 0.28 to 0.62]; p 
0.001) and 3-year (OR: 0.70 [95% CI: 0.53 to 0.92]; p 
0.01) follow-up. Although these analyses are prone to
confounding and do not consider differences in the duration
of dual antiplatelet therapy, these data support a default
strategy of DES for left main PCI except in cases in which
it is not anatomically feasible (e.g., very large reference
vessel diameter) or in which long-term dual antiplatelet
therapy is contraindicated.
PROVISIONAL VERSUS DEDICATED 2-STENT APPROACH FOR
THE DISTAL LEFT MAIN. The distal bifurcation is the most
ommon site of left main obstruction, and it represented
4% of the target lesions in the left main cohort of the
YNTAX trial (4). In observational studies, PCI of the left
ain ostium and/or shaft, which is technically less challeng-
ng, seems to be associated with lower rates of MACE
ompared with PCI of the bifurcation (27–29). Small
andomized trials of PCI with DES for bifurcation lesions
ave demonstrated that a provisional stenting strategy of the
istal bifurcation (stent the main vessel only, with optional
tenting of the side branch) is associated with reduced
eriprocedural MI, less contrast use, and decreased proce-
ural and fluoroscopy times compared with a systematic
-stent approach (both main vessel and side branch) (30). A
ooled analysis found that a provisional approach provided
imilarly beneficial outcomes even for more anatomically
omplex lesions (31). However, the target lesion involved
he left main bifurcation in only 2% of the enrolled patients
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October 23, 2012:1605–13 Left Main PCIin these studies, and side branch compromise may have
more profound acute and longer-term clinical impact in the
setting of the left main. In an observational study of 773
patients with distal left main disease, a single stent tech-
nique was associated with a reduced propensity-adjusted
risk of 2-year MACE as well as cardiac mortality and MI
compared with a 2-stent technique; final kissing balloon
dilation, regardless of stent approach, was also a predictor of
improved outcomes (32). Because stent technique is usually
dictated by plaque burden and coronary anatomy, the
observed differences in outcomes between 1- and 2-stent
approaches may depend on differences in the complexity of
the treated lesions. The current data support provisional
stenting as the primary strategy for approaching the left
main bifurcation, although there are several scenarios in
which a dedicated 2-stent approach for left main PCI is
reasonable and may be preferred. Some examples of anat-
omy favoring a 2-stent approach include: left circumflex
disease extending 5 mm from the carina, threatened
closure of the left circumflex, or when re-access to the left
circumflex would be particularly challenging (33).
2-STENT APPROACHES. An operator can select from a pleth-
ora of 2-stent techniques, including but not limited to crush,
culotte, T-stenting, T-and-protrusion, and simultaneous
kissing stents. The Nordic Stent Technique study randomly
assigned 424 patients who had a bifurcation lesion to crush
or culotte stenting; the left main was the target lesion in
10% of cases. At 6 months, there were no differences in
clinical outcomes between the 2 groups, although there was
significantly less angiographic restenosis in patients treated
with culotte stenting (4.5% vs. 10.5%, p  0.046). A
egistry of unprotected left main PCI showed no difference
n outcomes between the different 2-stent techniques (32),
ut the technique selection was not randomized, and the
tudy was underpowered to see differences in clinical out-
omes. Simultaneous kissing stents are associated with an
nacceptably high rate of target lesion revascularization
34), and when restenosis occurs, percutaneous reinterven-
ion is challenging. However, it can be useful when speed
nd simplicity, rather than longer-term outcomes, are the
riority. The optimal 2-stent approach should be dictated
y operator comfort and coronary anatomy (e.g., similar
iameters of the circumflex and left anterior descending
rteries favor culotte, dissimilar diameters favor crush, and a
ery steep angle of the bifurcation may favor a T- or
-and-protrusion technique).
INTRAVASCULAR IMAGING AND FUNCTIONAL ASSESSMENT
TO OPTIMIZE TECHNICAL RESULTS. Randomized trials in
he BMS era did not show a clinical benefit of routine IVUS
o guide PCI. However, because the true luminal diameter
f the left main is difficult to determine angiographically, and
ifurcation stent techniques can result in substantial stent
istortion (35), many operators advocate the use of intravas-
ular imaging with IVUS or optical coherence tomography to
elp guide the left main PCI procedure and to confirm the sechnical adequacy of the stent result (Fig. 3). After PCI for
on–left main lesions, edge dissections, stent underexpansion,
nd malapposition have been associated with stent thrombosis;
smaller, final minimal stented area has been associated with
he need for target lesion revascularization; and early malap-
osition may diminish the antirestenotic effect of DES (36,37).
he clinical sequelae of these phenomena are potentially
reater within the left main. A final minimal stent area 9.6
m2 has been associated with a very low rate of repeat
evascularization after left main PCI (38), and IVUS guidance
ed to a lower 3-year mortality rate compared with angio-
raphic guidance alone in 145 matched pairs of patients who
nderwent left main PCI with DES (25). Narrowing of the
eft circumflex ostium is not uncommon after crossover stent-
ng into the left anterior descending artery, and recent studies
sing intravascular imaging have demonstrated that the mech-
nism of this phenomenon is frequently carina shift, rather
han plaque shift, especially when the angle between the left
nterior descending and left circumflex arteries is narrow (39).
he degree of angiographic stenosis of the jailed left circumflex
stium after crossover stenting is frequently discordant with
unctional severity according to FFR (40), and therefore FFR
ay help the operator decide whether to provisionally stent a
pinched” left circumflex. Such a physiology-guided strategy to
rovisional stenting of the distal left main seems reasonable,
lthough its clinical safety and efficacy have not been assessed.
ANGIOGRAPHIC FOLLOW-UP. A rationale for routine sur-
eillance angiography after left main PCI arose from the
ndings of the ULTIMA (Unprotected Left Main Trunk
ntervention Multicenter Assessment) registry, in which
here seemed to be an early hazard for mortality after BMS
mplantation in the first 6 months after discharge (41).
owever, the SYNTAX trial demonstrated the excellent
afety profile of left main PCI with DES in the absence of
uch routine angiography, and angiographic follow-up is
ot mandated in the EXCEL trial protocol. A previous
lass IIa recommendation for angiographic follow-up
as removed from the 2011 ACCF/AHA/SCAI PCI
uidelines.
onclusions
vidence from RCTs involving more than 1,600 patients
ith left main disease who are suitable candidates for either
ABG or PCI suggests that PCI may provide at least
quivalent results to CABG in the setting of less complex
oronary anatomy. However, these individual trials were
nderpowered to detect differences in this endpoint, and, in
he case of the SYNTAX trial, this finding must be
onsidered hypothesis-generating given that the PCI did
ot achieve the primary endpoint in the overall trial. The
urability of outcomes must also be confirmed with longer-
erm follow-up. Intravascular imaging and/or functional
ssessment before and after intervention and a provisional
tent approach to left main bifurcation lesions may optimize
1612 Teirstein and Price JACC Vol. 60, No. 17, 2012
Left Main PCI October 23, 2012:1605–13technical and possibly clinical outcomes, although robust
data supporting these approaches are lacking. Clinical out-
comes after PCI appear worse in patients with more
complex coronary anatomy, in particular those with SYN-
TAX scores 32. The current ACCF/AHA/SCAI guide-
lines state that left main PCI is a reasonable alternative to
CABG in patients who have anatomic conditions associated
with good procedural and longer-term outcomes and who
are at increased risk for surgery. The EXCEL trial will
provide more definitive data regarding the safety and efficacy
of left main PCI compared with CABG in patients suitable
for either treatment strategy.
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Figure 3 Intravascular Imaging Guidance of Complex Left Main
(A) Baseline left coronary angiography demonstrating severe left main bifurcation
culotte technique and final kissing balloon dilation. (C) Intravascular ultrasound (IV
(arrows). (D) IVUS after repeat kissing dilation with larger diameter noncompliant
left main percutaneous coronary intervention (PCI) with drug-eluting stents may ide
underexpansion, lack of lesion coverage, and edge dissection, which could affect
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